HRP20070094T3 - NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI - Google Patents

NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI

Info

Publication number
HRP20070094T3
HRP20070094T3 HR20070094T HRP20070094T HRP20070094T3 HR P20070094 T3 HRP20070094 T3 HR P20070094T3 HR 20070094 T HR20070094 T HR 20070094T HR P20070094 T HRP20070094 T HR P20070094T HR P20070094 T3 HRP20070094 T3 HR P20070094T3
Authority
HR
Croatia
Prior art keywords
optionally substituted
hydrogen
6alkyl
groups
hydroxy
Prior art date
Application number
HR20070094T
Other languages
English (en)
Croatian (hr)
Inventor
Alihodzic Sulejman
Michael Berge John
Lewis Jarvest Richard
Original Assignee
Glaxo Group Limited
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0310962A external-priority patent/GB0310962D0/en
Priority claimed from GB0407391A external-priority patent/GB0407391D0/en
Application filed by Glaxo Group Limited, Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. filed Critical Glaxo Group Limited
Publication of HRP20070094T3 publication Critical patent/HRP20070094T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HR20070094T 2003-05-13 2004-05-11 NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI HRP20070094T3 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0310962A GB0310962D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0407391A GB0407391D0 (en) 2004-03-31 2004-03-31 Novel compounds
PCT/EP2004/005083 WO2004101587A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 memberred-ring compounds

Publications (1)

Publication Number Publication Date
HRP20070094T3 true HRP20070094T3 (hr) 2008-05-31

Family

ID=33454579

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070094T HRP20070094T3 (hr) 2003-05-13 2004-05-11 NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI

Country Status (15)

Country Link
US (1) US20070293472A1 (de)
EP (1) EP1628989B1 (de)
JP (1) JP2006528667A (de)
AR (1) AR044304A1 (de)
AT (1) ATE348837T1 (de)
CA (1) CA2525455A1 (de)
CL (1) CL2004001012A1 (de)
DE (1) DE602004003809T2 (de)
DK (1) DK1628989T3 (de)
ES (1) ES2278319T3 (de)
HR (1) HRP20070094T3 (de)
PL (1) PL1628989T3 (de)
PT (1) PT1628989E (de)
SI (1) SI1628989T1 (de)
WO (1) WO2004101587A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638549A4 (de) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc Neue antibakterielle mittel
DE602005015963D1 (de) * 2004-05-06 2009-09-24 Glaxosmithkline Zagreb Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
EP1945652A1 (de) * 2005-11-09 2008-07-23 Glaxo Group Limited Makrolone
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8796232B2 (en) 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
WO2011146829A1 (en) 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
WO2014145210A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4686207A (en) * 1985-11-12 1987-08-11 Abbott Laboratories Erythromycin A 11,12-carbonates and method of use
EP0465581B1 (de) * 1989-03-28 1995-10-04 Abbott Laboratories Erythromycinderivate
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
CA2253451A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
EP0895999A1 (de) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4"-substituierte Macrolidantibiotica
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
ATE348837T1 (de) 2007-01-15
SI1628989T1 (sl) 2007-06-30
EP1628989B1 (de) 2006-12-20
CL2004001012A1 (es) 2005-03-18
DK1628989T3 (da) 2007-10-08
US20070293472A1 (en) 2007-12-20
ES2278319T3 (es) 2007-08-01
JP2006528667A (ja) 2006-12-21
AR044304A1 (es) 2005-09-07
WO2004101587A1 (en) 2004-11-25
PT1628989E (pt) 2007-03-30
DE602004003809T2 (de) 2007-10-11
EP1628989A1 (de) 2006-03-01
DE602004003809D1 (de) 2007-02-01
PL1628989T3 (pl) 2007-05-31
CA2525455A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
YU48088B (sh) Derivati indola
KR950704313A (ko) 5-아릴인돌 유도체 및 세로토닌(5-ht₁)작용물질로서의 그의 용도(5-arylindole derivatives and their use as serotonin(5-ht₁)agonists)
AR082994A1 (es) Derivados de pirazina como bloqueadores del canal epitelial de sodio
DE60017115D1 (de) Amid-derivate und deren medizinische verwendung
CO5290258A1 (es) Derivados de fenilheteroalquilaminas, proceso para su prepracion y composiciones farmaceuticas que contienen dichos derivados
PE20030062A1 (es) Derivados aralquilsulfonil-3-(pirrol-2-ilmetiliden)-2-indolinona como inhibidores de quinasas
AR035548A1 (es) Compuestos organicos
AR046711A1 (es) 5-7-diaminopirazolo[4,3d]pirimidinas como inhibidores de la pde-5,composiciones farmaceuticas que las contienen y usos en el tratamiento de hipertensiones
AR010378A1 (es) Novedosos compuestos con efecto analgesico, uso de los mismos para la preparacion de un medicamento y como agente de diagnostico, composicion farmaceutica, proceso para la preparacion de dichos compuestos y compuestos intermediarios
TW200643015A (en) 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
CA2487542A1 (en) Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
FI913782A0 (fi) Isoxazolderivat.
AR007077A1 (es) Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento
IE901799L (en) Anti inflammatory aminophenol derivatives
AR044304A1 (es) Compuesto de macrolido de 14 y 15 miembros sustituido en la posicion 4'', procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende
AR035254A1 (es) Derivados fluorquinolonicos de oxazolidinonas utiles como antibacterianos, procedimiento para su obtencion y su utilizacion para la preparacion de una composicion farmaceutica
YU6799A (sh) Derivati tetrahidrohinolina kao antagonisti eaa
AR053311A1 (es) Macrolonas - quinolonas amino sustituidas
PE69398A1 (es) Antagonistas de receptor de benzoxazinona dopamina d4
PE20030705A1 (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
AR049269A1 (es) Macrolidos unidos por esteres, utiles para el tratamiento de infecciones microbianas. procesos de preparacion y composiciones farmaceuticas.
DK304289A (da) Benzenderivater
ATE95816T1 (de) 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung.
DE69910568D1 (de) Furopyridinderivate und ihre therapeutische verwendung